Protective effect of N-acetylcysteine on experimental chronic lead nephrotoxicity in immature female rats

Human and Experimental Toxicology

Volumn 29, Issue 7, 2010, Pages 581-591

  Wang, Lin ^a   Wang, Zhenyong ^a   Liu, Jianzhu ^a  

^a SHANDONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

antioxidants; kidney; lead; N acetylcysteine; oxidative stress; rats

Indexed keywords

ACETYLCYSTEINE; ALBUMIN; ANTIOXIDANT; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; GLUTATHIONE; LEAD; MALONALDEHYDE; PROTEIN; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DRUG MECHANISM; ENZYMURIA; FEMALE; HISTOPATHOLOGY; KIDNEY CELL; KIDNEY FUNCTION; KIDNEY TUBULE NECROSIS; LEAD POISONING; LIPID PEROXIDATION; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION; ANALYSIS OF VARIANCE; ANIMAL; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; KIDNEY CORTEX; KIDNEY DISEASES; METABOLISM; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; SINGLE BLIND PROCEDURE;

ANIMALIA; RATTUS;

ACETYLCYSTEINE; ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; FEMALE; FREE RADICAL SCAVENGERS; GLUTATHIONE; KIDNEY CORTEX; KIDNEY DISEASES; LEAD POISONING; MALONDIALDEHYDE; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SINGLE-BLIND METHOD;

EID: 77953861448     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327109357270     Document Type: Article

References (33)

1. Mahalley KR Relation between quantities of lead ingested and health effects of lead in humans. Pediatrics 1977; 59: 448-456.
2. Courtois E., Marques M., Barrientos A. Lead-induced downregulation of soluble guanylate cyclase in isolated rat aortic segments mediated by reactive oxygen species and cyclooxygenase-2. J Am Soc Nephrol 2003; 14: 1464-1470.
3. Ouafa R., Eddine DN Effect of some naturally antioxidants in the treatment of chronic lead intoxication. Toxicol lett (suppl) 2007; 172: 215.
4. Smith DR, Kahng MW, Quintanilla-Vega B., Fowler BA High-affinity renal lead-binding proteins in environmentally-exposed humans. Chem Biol Interact 1998; 115: 39-52.
5. Hotter G., Fels LM, Closa D., Roselló J., Stolte H., Gelpí E. Altered levels of urinary prostanoids in lead-exposed workers. Toxicol lett 1995; 77: 309-312.
6. Lin JL, Lin-Tan DT, Li YJ, Chen KH, Huang YL Low-level environmental exposure to lead and progressive chronic kidney diseases. Am J Med 2006; 119: 707.
7. Khalil-Manesh F., Gonick HC, Cohen AH, et al. Experimental model of lead nephropathy. I. Continuous high dose lead administration. Kidney Int 1992; 41: 1192-1203.
8. El-Sokkary GH, Abdel-Rahman GH, Kamel ES Melatonin protects against lead-induced hepatic and renal toxicity in male rats. Toxicology 2005; 213: 25-33.
9. Ercal N., Treeratphan P., Hammond TC, Mattews RH, Grannemann N., Spitz D. In vivo indices of oxidative stress in lead exposed C57BL/6 mice are reduced by treatment with meso-2, 3-dimercaptosuccinic acid or N-acetyl cysteine. Free Rad Biol Med 1996; 21: 157-161.
10. Hsu PC, Guo YL Antioxidant nutrients and lead toxicity. Toxicology 2002; 180: 33-44.
11. Tandon SK, Singh S., Prasad S., Srivastava S., Siddiqui MKJ. Reversal of lead-induced oxidative stress by chelating agent, antioxidant, or their combination in the rat. Environ Res 2002; 90: 61-66.
12. Gurer H., Ercal N. Can antioxidants be beneficial in the treatment of lead poisoning? Free Radic Biol Med 2000; 29: 927-945.
13. Flora SJS, Pande M., Mehta A. Beneficial effect of combined administration of some naturally occurring antioxidants (vitamins) and thiol chelators in the treatment of chronic lead intoxication. Chem Biol Interact 2003; 145: 267-280.
14. Afaq F., Abidi P., Rahman Q. N-acetyl L-cysteine attenuates oxidant-mediated toxicity induced by chrysotile fibers. Toxicol Lett 2000; 117: 53-60.
15. Wang L., Wang H., Hu M., Cao J., Chen D., Liu Z. Oxidative stress and apoptotic changes in primary cultures of rat proximal tubular cells exposed to lead. Arch Toxicol 2009; 83: 417-427.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
17. Ledwozwy A., Michalak J., Stepien A., Kadziolka A. The relationship plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin Chim Acta 1986; 155: 275-283.
18. Meister A., Anderson ME Glutathione. Annu Rev Biochem 1983; 52: 711-760.
19. Wedeen RP, Udasin I., Fiedler N., et al. Urinary biomarkers as indicators of renal disease. Ren Fail 1999; 21: 241-249.
20. Porter GA Urinary biomarkers and nephrotoxicity. Miner Electrolyte Metab 1994; 20: 181-186.
21. Rodriguez-Barbero A., López-Novoa JM, Arévalo M. Involvement of platelet-activating factor in gentamicin nephrotoxicity in rats. Exp Nephrol 1997; 5: 47-54.
22. Morales AI, Vicente-Sánchez C., Sandoval JM, et al. Protective effect of quercetin on experimental chronic cadmium nephrotoxicity in rats is based on its antioxidant properties. Food Chem Toxicol 2006; 44: 2092-2100. (Pubitemid 44537569)
23. Raab WP Diagnostic value of urinary enzyme determinations. Clin Chem 1972; 18: 5-25.
24. Sivaprasad TR, Malarkodi SP, Palaninathan V. Therapeutic efficacy of lipoic acid in combination with dimercaptosuccinic acid against lead-induced renal tubular defects and on isolated brush-border enzyme activities. Chem Biol Interact 2004; 147: 259-271.
25. Gruener N. Early detection of changes in kidney function in workers exposed to solvents and heavy metals. Isr J Med Sci 1992; 28: 605-607.
26. Trzcinka-Ochocka M., Jakubowski M., Razniewska G., Halatek T., Gazewski A. The effects of environmental cadmium exposure on kidney function: the possible influence of age. Environ Res 2004; 95: 143-150.
27. Lee JI, Kim MJ, Park CS, Kim MC Influence of ascorbic acid on BUN, creatinine, resistive index in canine renal ischemia-reperfusion injury. J Vet Sci 2006; 7: 79-81.
28. Fleury C., Mignotte B., Vayssière JL Mitochondrial reactive oxygen species in cell death signaling. Biochimie 2002; 84: 131-141.
29. Wallace DC A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005; 39: 359-407.
30. Foster KA, Galeffi F., Gerich FJ, Turner DA, Müller M. Optical and pharmacological tools to investigate the role of mitochondria during oxidative stress and neuro-degeneration. Prog Neurobiol 2006; 79: 136-171.
31. Farmand F., Ehdaie A., Roberts CK, Sindhu RK Lead-induced dysregulation of superoxide dismutases, catalase, glutathione peroxidase, and guanylate cyclase. Environ Res 2005; 98: 33-39.
32. Swierkosz TA, Mitchell JA, Warner TD, Botting RM, Vane JR Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br J Pharmacol 1995; 114: 1335-1342.
33. Lin JL, Lin-Tan DT, Yen TH, et al. Blood lead levels, malnutrition, inflammation, and mortality in patients with diabetes treated by long-term hemodialysis. Am J Kidney Dis 2008; 51: 107-115.